Published in Patient Care Law Weekly, March 21st, 2004
Both universities have taken an equity stake in Alteris as part of the licensing agreement. ALT-110 was originally identified by Albert Wong, MD, a founder of Alteris, while he was a researcher at Johns Hopkins. Alteris has previously licensed other technology rights relevant to ALT-110 from Thomas Jefferson University.
Splice variants result when...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.